Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation

Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation

Abstract Background Uncommon epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) is a rare subset of NSCLC. The aim of this study was to investigate the prevalence, characteristics, and clinical outcomes of metastatic NSCLC harboring uncommon EGFR mutation at Thailand’s...

Full description

Bibliographic Details
Main Authors: J. Chantharasamee, N. Poungvarin, P. Danchaivijitr, S. Techawatanawanna
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Cancer
Subjects:
Prevalence
Characteristics
Clinical outcomes
Metastatic non-small cell lung cancer (NSCLC)
Epidermal growth factor receptor (EGFR) mutation
Siriraj hospital
Online Access:http://link.springer.com/article/10.1186/s12885-019-5913-9

Internet

http://link.springer.com/article/10.1186/s12885-019-5913-9

Similar Items